Ombipla Trademark Details

This mark is dead with a status of Abandoned - After Publication. The last case file activity for this mark occured 8 years ago on Thursday, October 9, 2014, according to the United State Patent & Trademark Office
Word Mark Ombipla
Status Dead 605 — Abandoned - After Publication

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 86256784
Status Date Thursday, October 9, 2014
Filing Date Thursday, October 9, 2014
Attorney Marilyn F. Kelly

Correspondent

MARILYN F. KELLY
BRISTOL-MYERS SQUIBB COMPANY
PO BOX 4000
PRINCETON, NJ 08543-4000

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 8 — Abandoned
Status Date Thursday, October 9, 2014
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.